Research Topics
| Polina GermanSummaryAffiliation: Gilead Sciences Country: USA Publications
| Collaborators |
Detail Information
Publications
Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal functionPolina German
Gilead Sciences, Inc, Foster City, CA 94404, USA
J Acquir Immune Defic Syndr 61:32-40. 2012..COBI is a potent CYP3A inhibitor (pharmacoenhancer) currently in phase 3 testing with elvitegravir, atazanavir, and darunavir...
Pharmacokinetics and bioavailability of an integrase and novel pharmacoenhancer-containing single-tablet fixed-dose combination regimen for the treatment of HIVPolina German
Gilead Sciences, Inc, Foster City, CA 94404, USA
J Acquir Immune Defic Syndr 55:323-9. 2010....
Clinical pharmacokinetic and pharmacodynamic profile of the HIV integrase inhibitor elvitegravirSrinivasan Ramanathan
Gilead Sciences, Inc, Foster City, California 94404, USA
Clin Pharmacokinet 50:229-44. 2011....
